These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 18703023

  • 21. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
    Sinués B, Sáenz MA, Lanuza J, Bernal ML, Fanlo A, Juste JL, Mayayo E.
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):159-66. PubMed ID: 10067814
    [Abstract] [Full Text] [Related]

  • 22. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
    Chen Y, Xiao P, Ou-Yang DS, Fan L, Guo D, Wang YN, Han Y, Tu JH, Zhou G, Huang YF, Zhou HH.
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233
    [Abstract] [Full Text] [Related]

  • 23. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M, Pontes ZB, Gueguen R, Galteau MM, Siest G.
    Genet Epidemiol; 1994 Aug; 11(2):115-29. PubMed ID: 8013893
    [Abstract] [Full Text] [Related]

  • 24. Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2.
    MacLeod S, Sinha R, Kadlubar FF, Lang NP.
    Mutat Res; 1997 May 12; 376(1-2):135-42. PubMed ID: 9202749
    [Abstract] [Full Text] [Related]

  • 25. Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.
    Rasmussen BB, Brøsen K.
    Ther Drug Monit; 1996 Jun 12; 18(3):254-62. PubMed ID: 8738764
    [Abstract] [Full Text] [Related]

  • 26. Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore.
    Seow A, Zhao B, Lee EJ, Poh WT, Teh M, Eng P, Wang YT, Tan WC, Lee HP.
    Carcinogenesis; 2001 Apr 12; 22(4):673-7. PubMed ID: 11285205
    [Abstract] [Full Text] [Related]

  • 27. Genistein alters caffeine exposure in healthy female volunteers.
    Chen Y, Xiao CQ, He YJ, Chen BL, Wang G, Zhou G, Zhang W, Tan ZR, Cao S, Wang LP, Zhou HH.
    Eur J Clin Pharmacol; 2011 Apr 12; 67(4):347-353. PubMed ID: 21222115
    [Abstract] [Full Text] [Related]

  • 28. The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects.
    Welfare MR, Bassendine MF, Daly AK.
    Br J Clin Pharmacol; 2000 Mar 12; 49(3):240-3. PubMed ID: 10718779
    [Abstract] [Full Text] [Related]

  • 29. Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug.
    Vrtic F, Haefeli WE, Drewe J, Krähenbühl S, Wenk M.
    Br J Clin Pharmacol; 2003 Feb 12; 55(2):191-8. PubMed ID: 12580991
    [Abstract] [Full Text] [Related]

  • 30. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.
    Yoshida K, Osawa K, Kasahara M, Miyaishi A, Nakanishi K, Hayamizu S, Osawa Y, Tsutou A, Tabuchi Y, Shimada E, Tanaka K, Yamamoto M, Takahashi J.
    Asian Pac J Cancer Prev; 2007 Feb 12; 8(3):438-44. PubMed ID: 18159984
    [Abstract] [Full Text] [Related]

  • 31. Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study.
    Tao L, Xiang YB, Chan KK, Wang R, Gao YT, Yu MC, Yuan JM.
    Int J Cancer; 2012 Mar 01; 130(5):1174-83. PubMed ID: 21480221
    [Abstract] [Full Text] [Related]

  • 32. Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping.
    Kashuba AD, Bertino JS, Kearns GL, Leeder JS, James AW, Gotschall R, Nafziger AN.
    Clin Pharmacol Ther; 1998 May 01; 63(5):540-51. PubMed ID: 9630827
    [Abstract] [Full Text] [Related]

  • 33. Heterocyclic amine intake, smoking, cytochrome P450 1A2 and N-acetylation phenotypes, and risk of colorectal adenoma in a multiethnic population.
    Voutsinas J, Wilkens LR, Franke A, Vogt TM, Yokochi LA, Decker R, Le Marchand L.
    Gut; 2013 Mar 01; 62(3):416-22. PubMed ID: 22628494
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations.
    Fuhr U, Rost KL, Engelhardt R, Sachs M, Liermann D, Belloc C, Beaune P, Janezic S, Grant D, Meyer UA, Staib AH.
    Pharmacogenetics; 1996 Apr 01; 6(2):159-76. PubMed ID: 9156694
    [Abstract] [Full Text] [Related]

  • 35. Liu wei di huang wan, a well-known traditional Chinese medicine, induces CYP1A2 while suppressing CYP2A6 and N-acetyltransferase 2 activities in man.
    Chen Y, Kang Z, Yan J, Yang GP, Tan ZR, Zhou G, Ouyang DS.
    J Ethnopharmacol; 2010 Oct 28; 132(1):213-8. PubMed ID: 20723593
    [Abstract] [Full Text] [Related]

  • 36. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.
    Tsukino H, Kuroda Y, Nakao H, Imai H, Inatomi H, Osada Y, Katoh T.
    J Cancer Res Clin Oncol; 2004 Feb 28; 130(2):99-106. PubMed ID: 14648207
    [Abstract] [Full Text] [Related]

  • 37. Dietary effects of Sideritis scardica "mountain tea" on human in vivo activities of xenobiotic metabolizing enzymes in healthy subjects.
    Begas E, Kilindris T, Kouvaras E, Tsioutsioumi A, Kouretas D, Asprodini EK.
    Food Chem Toxicol; 2018 Dec 28; 122():38-48. PubMed ID: 30266316
    [Abstract] [Full Text] [Related]

  • 38. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status.
    Osawa Y, Osawa KK, Miyaishi A, Higuchi M, Tsutou A, Matsumura S, Tabuchi Y, Tsubota N, Takahashi J.
    Asian Pac J Cancer Prev; 2007 Dec 28; 8(1):103-8. PubMed ID: 17477782
    [Abstract] [Full Text] [Related]

  • 39. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2.
    Gago-Dominguez M, Bell DA, Watson MA, Yuan JM, Castelao JE, Hein DW, Chan KK, Coetzee GA, Ross RK, Yu MC.
    Carcinogenesis; 2003 Mar 28; 24(3):483-9. PubMed ID: 12663508
    [Abstract] [Full Text] [Related]

  • 40. N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.
    Aklillu E, Carrillo JA, Makonnen E, Bertilsson L, Djordjevic N.
    Eur J Clin Pharmacol; 2018 Jul 28; 74(7):903-911. PubMed ID: 29589062
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.